The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center

Bryan C. Morse^*, Christopher J. Dente, Erica I. Hodgman, Beth H. Shaz, Jeffrey M. Nicholas, Amy D. Wyrzykowski, Jeffrey P. Salomone, Gary A. Vercruysse, Grace S. Rozycki, David V. Feliciano

^*Corresponding author for this work